Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00599846 · ClinicalTrials.gov registry record

The Natural History of Geographic Atrophy Progression (GAP) Study

A clinical trial, sponsored by Alcon Research.

Terminated
Registry status
1,000
Enrollment target

NCT00599846: Clinical Trial study, sponsored by Alcon Research.

NCT00599846 is a clinical trial that was terminated before completion, run by Alcon Research. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00599846 was terminated before completion, sponsored by Alcon Research.

TERMINATED
Registry status
1,000 participants
Enrollment target

Study Summary

The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2007-12
Alcon Research

275 total trials

Why NCT00599846 stopped before completion

NCT00599846 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00599846 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00599846 about?

NCT00599846 is a clinical study titled "The Natural History of Geographic Atrophy Progression (GAP) Study". The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.

What is the current status of trial NCT00599846?

This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2007-12.

Who is sponsoring clinical trial NCT00599846?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00599846, the US trial registry maintained by the National Library of Medicine. NCT00599846 (large enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.